These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19159473)

  • 21. Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study.
    Kotz D; Brown J; West R
    Psychopharmacology (Berl); 2014 Jan; 231(1):37-42. PubMed ID: 23873417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
    Eisenberg MJ; Filion KB; Yavin D; Bélisle P; Mottillo S; Joseph L; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Pilote L
    CMAJ; 2008 Jul; 179(2):135-44. PubMed ID: 18625984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
    Wu P; Wilson K; Dimoulas P; Mills EJ
    BMC Public Health; 2006 Dec; 6():300. PubMed ID: 17156479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
    Wu L; Sun S; He Y; Zeng J
    Int J Environ Res Public Health; 2015 Aug; 12(9):10235-53. PubMed ID: 26308034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
    Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
    Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
    Gobarani RK; Ilomäki J; Wood S; Abramson MJ; Bonevski B; George J
    Addiction; 2022 Oct; 117(10):2683-2694. PubMed ID: 35603915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.
    Stapleton J; West R; Hajek P; Wheeler J; Vangeli E; Abdi Z; O'Gara C; McRobbie H; Humphrey K; Ali R; Strang J; Sutherland G
    Addiction; 2013 Dec; 108(12):2193-201. PubMed ID: 23859696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (3):CD000146. PubMed ID: 10908462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse prevention interventions for smoking cessation.
    Hajek P; Stead LF; West R; Jarvis M; Hartmann-Boyce J; Lancaster T
    Cochrane Database Syst Rev; 2013 Aug; (8):CD003999. PubMed ID: 23963584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing of smoking cessation medication in England since the introduction of varenicline.
    Langley TE; Huang Y; McNeill A; Coleman T; Szatkowski L; Lewis S
    Addiction; 2011 Jul; 106(7):1319-24. PubMed ID: 21395894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real world evaluation of three models of NHS smoking cessation service in England.
    Mardle T; Merrett S; Wright J; Percival F; Lockhart I
    BMC Res Notes; 2012 Jan; 5():9. PubMed ID: 22226240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.
    Kralikova E; Kmetova A; Stepankova L; Zvolska K; Davis R; West R
    Addiction; 2013 Aug; 108(8):1497-502. PubMed ID: 23668486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan.
    Hsueh KC; Hsueh SC; Chou MY; Pan LF; Tu MS; McEwen A; West R
    Psychopharmacology (Berl); 2014 Jul; 231(14):2819-23. PubMed ID: 24522334
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.